- Home
- CRMD vs AAC Comparison
CRMD vs AAC Comparison
Compare CRMD & AAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.51
N/A
Current Price
$10.07
Company Overview
Basic Information| Metric | CRMD | AAC |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 590.7M | 497.2M |
| IPO Year | 2009 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CRMD | AAC |
|---|---|---|
| Price | $8.51 | $10.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.83 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 147.6K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $311,709,000.00 | N/A |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.84 | ★ N/A |
| Revenue Growth | ★ 617.03 | N/A |
| 52 Week Low | $6.13 | $10.06 |
| 52 Week High | $13.83 | $10.15 |
Technical Indicators
Market Signals| Indicator | CRMD | AAC |
|---|---|---|
| Relative Strength Index (RSI) | 57.94 | N/A |
| Support Level | $8.09 | N/A |
| Resistance Level | $8.53 | N/A |
| Average True Range (ATR) | 0.33 | 0.00 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 82.61 | 0.00 |
Price Performance
Historical Comparison CRMD
AAC
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About AAC Ares Acquisition Corporation III Class A Ordinary Shares
Ares Acquisition Corp III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.